Devlieger Benjamin K, Rommens Pol M, Baranowski Andreas, Wagner Daniel
Department of Orthopaedics and Traumatology Westpfalz-Klinikum, 67655 Kaiserslautern, Germany.
Department of Orthopaedics and Traumatology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
J Clin Med. 2024 Aug 11;13(16):4707. doi: 10.3390/jcm13164707.
: The increasing numbers of already endemic hip fractures in the elderly taking anticoagulants is a growing concern for daily surgical practice. Ample evidence demonstrates decreased morbidity and mortality in the general population when surgery is performed at the earliest possibility. Direct anticoagulants are relatively new drugs that can cause increased perioperative bleeding. Current guidelines propose stopping the drug to allow for elimination before performing elective surgery. Optimal management in urgent hip surgery is presently based on expert opinion with arbitrary cut-offs. In this study, we investigated whether patients taking direct anticoagulants would benefit from early surgical treatment, regardless of the timing since last intake. : A total of 340 patients were included in the analysis, of which 59 took direct anticoagulants. The primary outcomes were time to surgery, postoperative transfusion rate, postoperative hemoglobin decrease, length of postoperative in-hospital stay (LOPS), revision rate, and complication rate (medical and surgical). Our findings showed that the anticoagulated group was fit for discharge earlier when operated on within 24 h ( = 0.0167). Postoperative transfusion and medical complication rate tended to be lower when the operation was performed earlier. Revision rate due to hematomas were higher in the direct anticoagulant group without a relationship to time to surgery. Simple linear regression could not determine a relationship between postoperative hemoglobin change and time to surgery. We suggest that directly anticoagulated patients needing hip fracture surgery must be considered for early surgery.
在接受抗凝治疗的老年人中,髋部骨折这种本就常见的疾病数量不断增加,这日益引起日常外科手术实践的关注。大量证据表明,在普通人群中,尽早进行手术可降低发病率和死亡率。直接抗凝剂是相对较新的药物,可导致围手术期出血增加。当前指南建议在进行择期手术前停用该药物以使其排出体外。目前,紧急髋部手术的最佳管理基于专家意见及任意设定的临界值。在本研究中,我们调查了服用直接抗凝剂的患者是否会从早期手术治疗中获益,而不考虑距上次服药的时间。:共有340例患者纳入分析,其中59例服用直接抗凝剂。主要结局指标包括手术时间、术后输血率、术后血红蛋白下降情况、术后住院时间(LOPS)、翻修率和并发症发生率(医疗和手术方面)。我们的研究结果表明,抗凝组在24小时内接受手术时更早适合出院( = 0.0167)。手术越早进行,术后输血和医疗并发症发生率往往越低。直接抗凝剂组因血肿导致的翻修率较高,且与手术时间无关。简单线性回归无法确定术后血红蛋白变化与手术时间之间的关系。我们建议,对于需要进行髋部骨折手术的直接抗凝患者,必须考虑尽早手术。